FDA Approves OXYCODONE AND ACETAMINOPHEN — Camber Pharmaceuticals, Inc.

Camber Pharmaceuticals gained FDA approval for its ANDA207419 formulation of oxycodone and acetaminophen tablets, granting the company the rights to supply a lower-cost alternative to the branded drug. This approval is poised to impact the market by intensifying competitive pricing and eroding the market share of the incumbent brand sponsor.